• Featured Story

    At first glance, it may seem like bioscience investing is so complicated and risky that it's hardly worth your time and money to invest, at least if you don't have someone knowledgeable to guide you.

    And it's true. Putting your money behind new, experimental drugs, without some guidance, is a crapshoot.

    But there's an approach to making profits from this sector that doesn't rely on breakthrough discoveries, expensive drug trials, or constant cash infusions through dilutive public offerings to fuel its engine.

    That's what makes the company we'll look at today such an attractive investment.

    Welcome to the lucrative world of generics...

    Full Story

Article Index

Sorry, no content matched your criteria.